Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Patient selection for heart transplant: balancing risk

Patient selection for heart transplant: balancing risk Purpose of reviewHeart failure incidence continues to rise despite a relatively static number of available donor hearts. Selecting an appropriate heart transplant candidate requires evaluation of numerous factors to balance patient benefit while maximizing the utility of scarce donor hearts. Recent research has provided new insights into refining recipient risk assessment, providing additional tools to further define and balance risk when considering heart transplantation.Recent findingsRecent publications have developed models to assist in risk stratifying potential heart transplant recipients based on cardiac and noncardiac factors. These studies provide additional tools to assist clinicians in balancing individual risk and benefit of heart transplantation in the context of a limited donor organ supply.SummaryThe primary goal of heart transplantation is to improve survival and maximize quality of life. To meet this goal, a careful assessment of patient-specific risks is essential. The optimal approach to patient selection relies on integrating recent prognostication models with a multifactorial assessment of established clinical characteristics, comorbidities and psychosocial factors. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in Organ Transplantation Wolters Kluwer Health

Patient selection for heart transplant: balancing risk

Download PDF
9 pages

Loading next page...
 
/lp/wolters-kluwer-health/patient-selection-for-heart-transplant-balancing-risk-9y1dZS9PJZ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1087-2418
eISSN
1531-7013
DOI
10.1097/mot.0000000000000943
Publisher site
See Article on Publisher Site

Abstract

Purpose of reviewHeart failure incidence continues to rise despite a relatively static number of available donor hearts. Selecting an appropriate heart transplant candidate requires evaluation of numerous factors to balance patient benefit while maximizing the utility of scarce donor hearts. Recent research has provided new insights into refining recipient risk assessment, providing additional tools to further define and balance risk when considering heart transplantation.Recent findingsRecent publications have developed models to assist in risk stratifying potential heart transplant recipients based on cardiac and noncardiac factors. These studies provide additional tools to assist clinicians in balancing individual risk and benefit of heart transplantation in the context of a limited donor organ supply.SummaryThe primary goal of heart transplantation is to improve survival and maximize quality of life. To meet this goal, a careful assessment of patient-specific risks is essential. The optimal approach to patient selection relies on integrating recent prognostication models with a multifactorial assessment of established clinical characteristics, comorbidities and psychosocial factors.

Journal

Current Opinion in Organ Transplantation – Wolters Kluwer Health

Published: Feb 3, 2022

References

  • Heart disease and stroke statistics—2020 update: a report from the American Heart Association
  • Statistics of heart failure and mechanical circulatory support in
  • Clinical Guide to Heart Transplantation
  • The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update
  • Comparison of echocardiographic and invasive measures of volaemia and cardiac performance in critically ill patients
  • Myocardial work assessment for the prediction of prognosis in advanced heart failure
  • Right heart catheterization in patients with advanced heart failure
  • Hemodynamic predictors of heart failure morbidity and mortality: fluid or flow?
  • Prognostic role of cardiac power index in ambulatory patients with advanced heart failure: Prognostic role of CPI in ambulatory patients with advanced HF
  • Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing
  • Cardiopulmonary exercise measures of men and women with HFrEF differ in their relationship to prognosis: the Henry Ford Hospital Cardiopulmonary Exercise Testing (FIT-CPX) project
  • Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years: VO2 and VE/VCO2 values in HF prognosis over time
  • Strategies of wait-listing for heart transplant vs durable mechanical circulatory support Alone for patients with advanced heart failure
  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC
  • Evaluation for heart transplantation and LVAD implantation
  • Mortality in patients with cardiogenic shock supported with VA ECMO: a systematic review and meta-analysis evaluating the impact of etiology on 29,289 patients
  • Veno-arterial extracorporeal membrane oxygenation as bridge to heart transplantation: the way forward
  • Bridge to heart transplantation in patients with cardiogenic shock: a 20-year experience with two different surgical strategies
  • Intra-aortic balloon pump bridging to heart transplantation: impact of the 2018 allocation change
  • One-year outcomes following heart transplantation under the new donor heart allocation system in the United States
  • Evolving trends in adult heart transplant with the 2018 heart allocation policy change
  • Evaluation of case volumes of a heart transplant program and short-term outcomes after changes in the united network for organ sharing donor heart allocation system
  • Impella RP as a bridge to cardiac transplant for refractory late right ventricular failure in setting of left ventricular assist device
  • Direct bridging to cardiac transplantation with the surgically implanted Impella 5.0 device
  • The new heart transplant allocation system: Early observations and mechanical circulatory support considerations
  • Contemporary use of venoarterial extracorporeal membrane oxygenation: insights from the multicenter RESCUE registry
  • Incidence and impact of primary graft dysfunction in adult heart transplant recipients: a systematic review and meta-analysis
  • Venoarterial extracorporeal membrane oxygenation as a bridge to recovery or bridge to heart replacement therapy in refractory cardiogenic shock
  • Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients
  • Utility of the INTERMACS profile at the time of assessment for heart transplant
  • State-of-the-art machine learning algorithms for the prediction of outcomes after contemporary heart transplantation: results from the UNOS database
  • Risk prediction models for survival after heart transplantation: a systematic review
  • INTERMACS profiles of advanced heart failure: the current picture
  • Continuously updated estimation of heart transplant waitlist mortality
  • Heart transplant recipient selection issues: limited assets, infinite possibilities
  • A mortality risk score for septuagenarians undergoing orthotopic heart transplantation
  • The impact of donor sex on heart transplantation outcomes—a study of over 60,000 patients in the United States
  • Heart transplantation in women
  • Implications of obesity across the heart failure continuum
  • Bariatric surgery in patients with obesity and ventricular assist devices considered for heart transplantation: systematic review and individual participant data meta-analysis
  • Canadian Cardiovascular Society/Canadian Cardiac Transplant Network position statement on heart transplantation: patient eligibility, selection, and post-transplantation care
  • Prevalence and characterization of frailty, depression, and cognitive impairment in patients listed for heart transplantation: results of the FELICITAR prospective registry
  • Differences in handgrip strength protocols to identify sarcopenia and frailty – a systematic review
  • Nutrition, obesity, and cachexia in patients with heart failure: a consensus statement from the Heart Failure Society of America Scientific Statements Committee
  • Frailty of the heart recipient
  • The utility of boxing for cardiac prehabilitation
  • The role of cardiac rehabilitation in reducing major adverse cardiac events in heart transplant patients
  • Prognostic significance of lung diffusion capacity and spirometric parameters in relation to hemodynamic status in heart transplant candidates
  • All-cause mortality predicted by peak oxygen uptake differs depending on spirometry pattern in patients with heart failure and reduced ejection fraction
  • Cardiac outcomes in isolated heart and simultaneous kidney and heart transplants in the United States
  • Consensus conference on heart-kidney transplantation
  • Advances in noninvasive assessment of hepatic fibrosis
  • Heart transplantation for advanced heart failure
  • MELD-XI score is associated with short-term adverse events in patients with heart failure with preserved ejection
  • Hepatorenal dysfunction assessment with the model for end-stage liver disease excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients
  • Type 2 diabetes mellitus and heart failure, a scientific statement from the American Heart Association and Heart Failure Society of America
  • Advances in the treatment of cardiac amyloidosis
  • Emerging therapy in light-chain and acquired transthyretin-related amyloidosis: an Italian single-centre experience in heart transplantation
  • Outcomes in patients with cardiac amyloidosis undergoing heart transplantation
  • Guidance from the International Society of Heart and Lung Transplantation regarding the SARS CoV-2 pandemic
  • Outcomes of adult heart transplantation using hepatitis C-positive donors
  • Expanding heart transplant in the era of direct-acting antiviral therapy for hepatitis C
  • Preoperative anemia and transfusion in cardiac surgery: a single-centre retrospective study
  • The emerging role of iron in heart failure and vascular calcification in CKD
  • Psychosocial evaluation of candidates for heart transplant and ventricular assist devices: beyond the current consensus
  • The 2018 ISHLT/APM/AST/ICCAC/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support
  • Prescription opioid use before and after heart transplant: associations with posttransplant outcomes